Clinical research & EBM · Reference
What is a surrogate endpoint?
A surrogate endpoint is a substitute outcome — often a biomarker such as blood pressure or a laboratory value — measured in place of a clinical endpoint that matters directly to patients. Surrogates can speed up research, but they are only reliable when validated against the true outcome.
Surrogate versus clinical endpoints
A clinical endpoint is an outcome that matters directly to people — how they feel, function or survive. A surrogate endpoint stands in for it: a measurement believed to track the clinical outcome but observable sooner or more easily, such as a biomarker or imaging finding. Trials often turn to surrogates because clinical endpoints can take years to appear and require very large studies to capture enough events. Measuring a surrogate that changes within weeks or months can shrink a trial dramatically — the methodological appeal that makes surrogates attractive in research and regulation.
When a surrogate is valid
The central caveat is that a surrogate is only trustworthy if a treatment’s effect on it reliably predicts the effect on the clinical outcome. Establishing this — validation — generally requires evidence that the surrogate lies on the causal pathway and that interventions changing the surrogate change the true outcome in the same direction and proportion. A merely correlated marker is not enough: correlation between a surrogate and an outcome does not guarantee that altering the surrogate alters the outcome. Validation is demanding, which is why genuinely validated surrogates are relatively few.
Why surrogates can mislead
History offers cautionary cases where a treatment improved a surrogate yet harmed patients on the outcome that mattered, because the surrogate captured only part of a complex biology. This is the core risk: a surrogate may respond to a treatment through a pathway unrelated to — or even opposed to — the clinical benefit. For this reason regulators distinguish validated surrogates from those accepted only as "reasonably likely" to predict benefit, sometimes with a requirement to confirm clinical outcomes later. Read as a methodology concept, a surrogate endpoint is a research-design trade-off, not clinical advice.
Key facts
At a glance
- Definition: Substitute outcome standing in for a clinical endpoint
- Often a: Biomarker or physiological measurement
- Benefit: Faster, smaller trials than clinical endpoints allow
- Requirement: Validation against the true outcome
- Key caveat: Correlation alone does not justify a surrogate
- Risk: May improve while the real outcome worsens
Common questions
FAQ
What is the difference between a surrogate and a clinical endpoint?+
A clinical endpoint is an outcome that matters directly to people, such as survival or a major event. A surrogate endpoint is a substitute — usually a biomarker — measured in its place because it appears sooner or more easily, but it only stands in validly when shown to predict the clinical outcome.
When can a surrogate endpoint be trusted?+
A surrogate is trustworthy only when a treatment’s effect on it reliably predicts the effect on the clinical outcome. This validation generally requires evidence that the surrogate lies on the causal pathway; mere correlation between marker and outcome is not sufficient.
Why can surrogate endpoints be misleading?+
A surrogate may capture only part of a complex biology, so a treatment can improve the surrogate while harming the outcome that matters. Because of this risk, regulators distinguish validated surrogates from those accepted only as reasonably likely to predict benefit, often requiring later confirmation.
Going deeper
Related on CASRAI
- Composite endpoint →
- Randomized controlled trial →
- Levels of evidence →
- Clinical trial →
- Clinical research hub →
Sources
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
